[1]
M. Wieteska, A. Kaczyńska, D. Maj, P. Stanicki, A. Chałupnik, and P. Wójcik, “Metformin as a medicine decreasing cardiovascular risk in patients suffering from type 2 diabetes mellitus”, J Educ Health Sport, vol. 10, no. 8, pp. 105–111, Aug. 2020.